Cellular Metabolism in Hematologic Malignancies: From Evolving Science to Therapeutic Potential -Over 80 years ago, world-renowned biochemist Otto Heinrich Warburg observed that cancer cells exhibited high glycolysis (glucose conversion to lactic acid) even in the presence of oxygen (Warburg effect). However, not until the last decade did the reprogramming of cellular metabolism regain deserved attention for its role in cancer.
Describe how metabolic reprogramming contributes to tumor transformation and sustains progression in blood cancer cells.
Assess the therapeutic potential of targeting metabolic changes as they relate specifically to hematologic malignancies.
Apply new strategies for incorporating therapies that target metabolism in blood cancers.
Utilize the information presented from current and future clinical trials that evaluate cancer metabolism in order to better manage patients with hematologic malignancies.
Explain the basis for therapies that affect cancer cell metabolism.
3.25 Free CEUs for Social Workers
This course also offers Free CME for Physicians